Study of a device to close the artery after heart procedures
This trial tests a device that helps close the puncture site in your leg after certain heart or blood vessel procedures. It aims to reduce bleeding and speed up recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You are having a procedure through an artery in your leg (femoral artery).
- The procedure uses a sheath (a small tube) sized 5F to 8F.
- You can understand the trial and agree to follow its schedule.
- You do not have severe bleeding disorders or other high-risk conditions.
- You are able to walk at least 6 meters without help.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new device that seals the small hole in the groin artery after procedures like TAVI or EVAR. It aims to stop bleeding quickly and safely, helping you recover faster.
This trial tests a device that helps close the puncture hole in your leg vein after a heart procedure, which may reduce bleeding and help you recover faster.
This study tests a new device that closes the large hole in the groin after certain heart or blood vessel procedures. It may help people who need a large tube (catheter) in their leg during these procedures.
This study compares two ways to close the vein entry after heart ablation for AFib: the LockeT device versus manual compression. It helps find which method works better.
This trial tests a new device called xDot that helps close the small hole in the leg after a heart procedure like a valve replacement or aneurysm repair. It is a feasibility study, meaning the device is being tested for safety and how well it works in people.
This study tests a device that helps close the small hole left in your groin after a heart or blood vessel procedure. It aims to stop bleeding quickly so you can recover safely and faster.
Hear when a new Hemostasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.